Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-05 Purchase | 2025-11-06 08:01 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 5,000 | $5.72 | $28,600 | 3,525,924 (Direct) | View |
| 2025-11-05 Purchase | 2025-11-06 08:00 am | Nuvectis Pharma Inc. | NVCT | Sanchez Juan Director | 13,000 | $5.79 | $75,270 | 78,565 (Indirect Direct) | View |
| 2025-11-05 Purchase | 2025-11-06 08:00 am | Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director | 11,000 | $5.84 | $64,240 | 124,760 (Direct) | View |
| 2025-10-23 Purchase | 2025-10-29 08:00 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 154,770 | $6.1839 | $957,083 | 3,245,897 (Indirect Direct) | View |
| 2025-06-20 Purchase | 2025-06-24 5:14 pm | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 5,603 | $7.99 | $44,768 | 3,091,127 (Indirect Direct) | View |
| 2025-06-17 Purchase | 2025-06-20 09:50 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 33,442 | $8.0597 | $269,532 | 2,976,203 (Indirect) | View |
| 2025-05-12 Purchase | 2025-05-13 6:36 pm | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 21,167 | $8.11 | $171,664 | 2,942,761 (Indirect) | View |
| 2025-05-08 Purchase(A) | 2025-05-12 09:25 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 27,662 | $8.9387 | $247,263 | 2,936,594 (Indirect) | View |
| 2025-05-06 Purchase | 2025-05-09 6:53 pm | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 27,411 | $8.5968 | $235,647 | 2,911,532 (Indirect) | View |
| 2025-02-07 Purchase | 2025-02-11 5:58 pm | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 240,000 | $5 | $1,200,000 | 2,884,121 (Indirect) | View |
| 2024-12-24 Purchase | 2024-12-26 08:00 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 4,500 | $4.65 | $20,925 | 3,270,924 (Direct) | View |
| 2024-12-12 Purchase(A) | 2024-12-16 5:37 pm | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 49,121 | $4.6608 | $228,941 | 2,644,121 (Direct) | View |
| 2024-12-13 Purchase | 2024-12-16 08:00 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 17,000 | $4.7 | $79,900 | 2,612,000 (Direct) | View |
| 2024-11-19 Purchase | 2024-11-20 08:30 am | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off | 2,000 | $4.99 | $9,980 | 1,506,319 (Direct) | View |
| 2024-11-15 Purchase | 2024-11-18 08:30 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 20,000 | $4.92 | $98,400 | 3,266,424 (Direct) | View |
| 2024-11-07 Sale | 2024-11-08 3:59 pm | Nuvectis Pharma Inc. | NVCT | Carson Michael J. Vice President, Finance | 2,755 | $8.159 | $22,478 | 87,918 (Direct) | View |
| 2024-05-14 Purchase | 2024-05-15 09:16 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 1,940 | $6.74 | $13,076 | 3,246,424 (Direct) | View |
| 2024-05-10 Purchase | 2024-05-13 08:51 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 2,000 | $6.4 | $12,800 | 3,244,484 (Direct) | View |
| 2024-05-10 Purchase | 2024-05-13 08:49 am | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off | 500 | $6.29 | $3,145 | 1,504,319 (Direct) | View |
| 2024-05-10 Purchase | 2024-05-13 08:47 am | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 1,113 | $6.32 | $7,034 | 1,493,068 (Direct) | View |
| 2024-03-18 Purchase | 2024-03-19 08:00 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 5,000 | $10.29 | $51,450 | 3,242,484 (Direct) | View |
| 2023-10-10 Purchase | 2023-10-12 4:05 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 640 | $11.08 | $7,091 | 3,237,484 (Direct) | View |
| 2023-10-06 Purchase | 2023-10-10 08:30 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 1,080 | $11.21 | $12,105 | 3,236,844 (Direct) | View |
| 2023-10-04 Purchase | 2023-10-06 08:37 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 3,220 | $11.01 | $35,455 | 3,235,764 (Direct) | View |
| 2023-08-15 Purchase | 2023-08-16 4:05 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 350 | $14.61 | $5,112 | 3,232,544 (Direct) | View |
| 2023-08-08 Purchase | 2023-08-11 6:07 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 300 | $14.73 | $4,418 | 3,232,194 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-09-22 Option Award | 2025-10-31 08:01 am | N/A N/A | Nuvectis Pharma Inc. | NVCT | Sanchez Juan Director | 30,000 | $0 | 65,565 (Direct) | View |
Ownership | 2025-10-31 08:00 am | N/A N/A | Nuvectis Pharma Inc. | NVCT | Sanchez Juan Director | 0 | $0 | 35,565 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-12 4:31 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director | 30,000 | $0 | 113,760 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-12 4:30 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Oliviero James F III Director | 30,000 | $0 | 87,828 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-12 4:30 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Hoberman Kenneth Director | 30,000 | $0 | 133,140 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 6:13 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 150,000 | $0 | 1,643,068 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 6:12 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off | 150,000 | $0 | 1,656,319 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 6:10 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Carson Michael J. Vice President, Finance | 51,000 | $0 | 138,918 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 6:09 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 250,000 | $0 | 3,520,924 (Direct) | View |
| 2023-01-03 Option Award | 2024-11-08 3:59 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Carson Michael J. Vice President, Finance | 63,373 | $0 | 87,918 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-13 4:22 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director | 30,000 | $0 | 83,760 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-13 4:22 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Hoberman Kenneth Director | 30,000 | $0 | 103,140 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-13 4:21 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Oliviero James F III Director | 30,000 | $0 | 57,828 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 4:31 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off | 130,000 | $0 | 1,503,819 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 4:30 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 130,000 | $0 | 1,491,955 (Direct) | View |